Nanotein engages Akron Bio for the cGMP production of its NanoSpark™ STEM-T Soluble T Cell Activator
BERKELEY, Calif.--(BUSINESS WIRE)--Nanotein Technologies, Inc. (“Nanotein”), a technology development company with next-generation immune cell activation reagents leveraging its proprietary NanoSpark® ...
News-Medical.Net on MSN
New approach harnesses tumor's own machinery to produce immune-stimulating molecules
By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers ...
Prognosis is extremely poor for patients with head and neck squamous cell carcinoma (HNSCC), which accounts for around 90% of all head and neck cancer. Especially in the more aggressive subtype of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback